| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $468.7M | -3.9% |
| Cost of Revenue | $280.2M | -8.7% |
| Gross Profit | $188.6M | +4.1% |
| R&D Expense | $9.6M | -25.9% |
| SG&A Expense | $63.6M | -8.0% |
| Operating Income | -$43.0M | +53.3% |
| Pre-tax Income | -$51.3M | +47.7% |
| Income Tax | $207K | +228.6% |
| Net Income | -$51.4M | +47.5% |
| EPS (Basic) | $0.48 | +152.7% |
| EPS (Diluted) | $0.48 | +152.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.3M | -16.1% |
| Accounts Receivable | $41.3M | +24.9% |
| Inventory | $59.7M | +5.0% |
| Current Assets | $136.7M | +8.2% |
| Total Assets | $296.3M | -3.8% |
| Current Liabilities | $101.5M | +0.5% |
| Long-term Debt | $126.7M | +79.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.8M | -89.5% |
| Capital Expenditures | $8.1M | +11.5% |
| Investing Cash Flow | -$8.3M | -9.9% |
| Financing Cash Flow | $37.4M | +36.0% |
| Free Cash Flow | -$41.9M | -67.0% |
| $325.9M |
| +13.3% |
| Stockholders' Equity | -$29.7M | -247.0% |